Table 2.
Comparison of patients with and without strict glycaemic control after 5 years; age at diagnosis, weight at time of diagnosis (baseline), weight after 5 years, glycated haemoglobin (HbA1c) at time of diagnosis (baseline), low‐density lipoprotein (LDL cholesterol), proinsulin c‐peptide (C‐peptide), total daily insulin dose after 5 years. The P‐value indicates the significance of the association between late strict control and the given parameter
| Late strict controla | Yes (N = 84) | No (N = 196) | Number of observations | P‐value |
|---|---|---|---|---|
| Age at onset (y) | 37.8 | 36.6 | 280 | 0.3 |
| Weight, baseline (kg) | 71.6 | 70.8 | 194 | 0.5 |
| Weight, after five years (kg) | 76.6 | 75.5 | 278 | 0.6 |
| HbA1c, baseline (mmol/mol (%)) | 103 (11.6) | 107 (11.9) | 280 | 0.3 |
| LDL cholesterol (mmol/L) | 3.0 | 2.8 | 258 | 0.7 |
| C‐peptide, baseline (pmol/L) | 369.2 | 355.7 | 265 | 0.4 |
| Total daily insulin dose after 5 years (IU) | 34.8 | 50.6 | 279 | <0.0001 |
a
Late strict control: HbA1c <53 mmol/mol (<7%) anytime during the fifth year after diagnosis.